The effect of age on the activity and molecular properties of human brain monoamine oxidase

Adolfsson, R., Gottfries, C.-G., Roos, B.-E., Winblad, B. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm.45, 81?105 (1979).

Adolfsson, R., Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci.27, 1029?1034 (1980).

Andén, N.-E., Bédard, P., Fuxe, K., Ungerstedt, U. Early and selective increase in brain dopamine levels after axotomy. Experientia28, 300?301 (1972).

Buffoni, F., Ignesti, G., Pirisino, R., Cortesini, C. Platelet monoamine oxidase, plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients. Med. Biol.55, 109?111 (1977).

Callingham, B. A., Laverty, R. Studies on the nature of the increasing monoamine oxidase activity in the rat heart after adrenalectomy. J. Pharm. Pharmacol.25, 940?947 (1973).

Carlsson, A. The impact of catecholamine research on medical science and practice. In: Catecholamines: Basic and Clinical Frontiers (Usdin, E., Kopin, I. J., Barchas, J., eds.), Vol. 1, pp. 4?19. New York: Pergamon Press. 1979.

Colon, E. J. The cerebral cortex in presenil dementia, a quantitative analysis. Acta Neuropath. (Berlin)23, 281?290 (1973).

Eckert, B., Gottfries, C.-G., von Knorring, L., Oreland, L., Wiberg, Å., Winblad, B. Brain and platelet monoamine oxidase in schizophrenics and cycloid psychotics. Progr. Neuropsychopharmacol.4, 57?68 (1980).

Fowler, C. J., Oreland, L., Marcusson, J., Winblad, B. Titration of human brain monoamine oxidase-A and -B by clorgyline and 1-deprenil. N.S. Arch. Pharmacol.311, 263?272 (1980 a).

Fowler, C. J., Wiberg, Å., Oreland, L., Winblad, B. Titration of human brain type-B monoamine oxidase. Neurochem. Res.5, 697?708 (1980 b).

Fowler, C. J., Ekstedt, B., Egashira, T., Kinemuchi, H., Oreland, L. The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem. Pharmacol.28, 3063?3068 (1979 a).

Fowler, C. J., Oreland, L., Wiberg, Å., Carlsson, A., Magnusson, T. The inhibition of rat brain monoamine oxidase-B by J-508 [N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride], and its use for the titration of this enzyme form. Med. Biol.57, 406?411 (1979 b).

Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B. Brain levels of monoamine oxidase in depression. LancetII, 360?361 (1974).

Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem.25, 667?673 (1975).

Green, D. E., Mii, S., Kohout, P. M. Studies on the terminal electron transport system. I. Succinic dehydrogenase. J. Biol. Chem.217, 551?567 (1955).

Grote, S. S., Moses, S. G., Robins, E., Hudgens, R. W., Croninger, A. B. A study of selected catecholamine metabolizing enzymes: a comparison of depressive suicides and alcohol suicides with controls. J. Neurochem.23, 791?802 (1974).

Johnston, J. P. Some observations on a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol.17, 1285?1297 (1968).

Knoll, J., Magyar, K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol.5, 393?408 (1972).

Linhardt, K., Walter, K. Phosphatases (phosphomonoesterases). In: Methods of Enzymatic Analysis (Bergmeyer, H. U., ed.), pp. 779?787. New York: Academic Press. 1963.

Mac Kay, A. V. P., Davies, P., Dewar, A. J., Yates, C. M. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J. Neurochem.30, 827?839 (1978).

Mac Pike, A. D., Meier, H. Genotype dependence of monoamine oxidase in inbred strains of mice. Experientia32, 979?980 (1976).

Mantle, T. J., Garrett, N. J., Tipton, K. F. The development of monoamine oxidase in rat liver and brain. FEBS Letts.64, 227?230 (1976).

Markwell, M. A. K., Haas, S. M., Bieber, L. L., Tolbert, N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analyt. Biochem.87, 206?210 (1978).

Oreland, L. The activity of human brain and thrombocyte monoamine oxidase (MAO) in relation to various psychiatric disorders. I. MAO activity in some disease states. In: Monoamine Oxidase; Structure, Function and Altered Functions (Singer, T. P., Von Korff, R. W., Murphy, D. L., eds.), pp. 379?387. New York: Academic Press. 1979.

Oreland, L., Fowler, C. J., Carlsson, A., Magnusson, T. Monoamine oxidase-A and -B activity in the rat brain after hemitransection. Life Sci.26, 139?146 (1980).

Robinson, D. S. Changes in monoamine oxidase and monoamines with human development and aging. Fed. Proc.34, 103?107 (1975).

Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L., Sylwester, D. Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. Gen. Psychiat.24, 536?539 (1971).

Robinson, D. S., Sourkes, T. L., Nies, A., Harris, L. S., Spector, S., Bartlett, D. L., Kaye, L. S. Monoamine metabolism in human brain. Arch. Gen. Psychiat.34, 89?92 (1977).

Roth, J. A. Evidence for a single catalytic binding site on human brain type B monoamine oxidase. J. Neurochem.27, 1107?1112 (1976).

Schefer, W. F. Hippocampal pathology as a possible factor in the pathogenesis of senile dementias. Neurosci. Behav. Physiol.8, 236?239 (1977).

Shih, J. Monoamine oxidase in aging human brain. In: Monoamine Oxidase; Structure, Function and Altered Functions (Singer, T. P., Von Korff, R. W., Murphy, D. L., eds.), pp. 413?421. New York: Academic Press. 1979.

Siegel, L., Englard, S. Beef heart malic dehydrogenase. I. Properties of the enzyme purified from extracts of acetone-dried powders. Biochim. Biophys. Acta54, 67?76 (1961).

Strolin Benedetti, M., Keane, P. E.: Differential changes in monoamine oxidase A and B activity in the aging rat brain. J. Neurochem. (in press).

Student, A. K., Edwards, D. J. Subcellular localization of type A and B monoamine oxidase in rat brain. Biochem. Pharmacol.26, 2337?2342 (1977).

Tipton, K. F., Houslay, M. D., Garrett, N. J. Allotopic properties of human brain monoamine oxidase. Nature New Biol. (Lond.)246, 213?214 (1973).

Vander Wende, C., Spoerlein, M. T. Effect of narcotics on monoamine oxidase activity of mouse brain. Res. Comm. Chem. Path. Pharmacol.24, 103?113 (1979).

White, H. L., Glassman, A. T. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitors, and attempts to separate enzyme forms. J. Neurochem.29, 987?997 (1977).

Wiberg, Å.: Mitochondrial monoamine oxidase; studies on its activity in some psychiatric diseases. Umeå University Medical Dissertations, New Series No. 41 (1978).